Literature DB >> 24831864

Cardiovascular disease is associated with COPD severity and reduced functional status and quality of life.

Jennifer L Black-Shinn1, Gregory L Kinney, Anastasia L Wise, Elizabeth A Regan, Barry Make, Mori J Krantz, R Graham Barr, James R Murphy, David Lynch, Edwin K Silverman, James D Crapo, John E Hokanson.   

Abstract

INTRODUCTION: Smoking is a major risk factor for both cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD). More individuals with COPD die from CVD than respiratory causes and the risk of developing CVD appears to be independent of smoking burden. Although CVD is a common comorbid condition within COPD, the nature of its relationships to COPD affection status and severity, and functional status is not well understood.
METHODS: The first 2,500 members of the COPDGene cohort were evaluated. Subjects were current and former smokers with a minimum 10 pack-year history of cigarette smoking. COPD was defined by spirometry as an FEV1/FVC < lower limit of normal (LLN) with further identification of severity by FEV1 percent of predicted (GOLD stages 2, 3, and 4) for the main analysis. The presence of physician-diagnosed self-reported CVD was determined from a medical history questionnaire administered by a trained staff member.
RESULTS: A total of 384 (15%) had pre-existing CVD. Self-reported CVD was independently related to COPD (Odds Ratio = 1.61, 95% CI = 1.18-2.20, p = 0.01) after adjustment for covariates with CHF having the greatest association with COPD. Within subjects with COPD, pre-existing self-reported CVD placed subjects at greater risk of hospitalization due to exacerbation, higher BODE index, and greater St. George's questionnaire score. The presence of self-reported CVD was associated with a shorter six-minute walk distance in those with COPD (p < 0.05).
CONCLUSIONS: Self-reported CVD was independently related to COPD with presence of both self-reported CVD and COPD associated with a markedly reduced functional status and reduced quality of life. Identification of CVD in those with COPD is an important consideration in determining functional status.

Entities:  

Keywords:  co-morbidities; pulmonary heart function

Mesh:

Year:  2014        PMID: 24831864      PMCID: PMC4467820          DOI: 10.3109/15412555.2014.898029

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  27 in total

1.  Trends in causes of death among the elderly.

Authors:  N R Sahyoun; H Lentzner; D Hoyert; K N Robinson
Journal:  Aging Trends       Date:  2001-03

2.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

3.  Annual smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 1997-2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-07-01       Impact factor: 17.586

4.  Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study.

Authors:  Emily S Wan; John E Hokanson; James R Murphy; Elizabeth A Regan; Barry J Make; David A Lynch; James D Crapo; Edwin K Silverman
Journal:  Am J Respir Crit Care Med       Date:  2011-04-14       Impact factor: 21.405

5.  Genetic epidemiology of COPD (COPDGene) study design.

Authors:  Elizabeth A Regan; John E Hokanson; James R Murphy; Barry Make; David A Lynch; Terri H Beaty; Douglas Curran-Everett; Edwin K Silverman; James D Crapo
Journal:  COPD       Date:  2010-02       Impact factor: 2.409

6.  C-reactive protein and myocardial infarction.

Authors:  Pamela Sakkinen; Robert D Abbott; J David Curb; Beatriz L Rodriguez; Katsuhiko Yano; Russell P Tracy
Journal:  J Clin Epidemiol       Date:  2002-05       Impact factor: 6.437

7.  Plasma levels of TNF-alpha, IL-6, and IL-10 and their relationship with left ventricular diastolic function in patients with stable angina pectoris and preserved left ventricular systolic performance.

Authors:  Wojciech Kosmala; Roksolana Derzhko; Monika Przewlocka-Kosmala; Alina Orda; Walentyna Mazurek
Journal:  Coron Artery Dis       Date:  2008-09       Impact factor: 1.439

8.  The direct medical costs of undiagnosed chronic obstructive pulmonary disease.

Authors:  Douglas W Mapel; Scott B Robinson; Homa B Dastani; Hemal Shah; Amy L Phillips; Eva Lydick
Journal:  Value Health       Date:  2008-01-08       Impact factor: 5.725

9.  Smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 2000-2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-11-14       Impact factor: 17.586

Review 10.  Chronic obstructive pulmonary disease.

Authors:  Marc Decramer; Wim Janssens; Marc Miravitlles
Journal:  Lancet       Date:  2012-02-06       Impact factor: 79.321

View more
  12 in total

Review 1.  Clinical Epidemiology of COPD: Insights From 10 Years of the COPDGene Study.

Authors:  Diego J Maselli; Surya P Bhatt; Antonio Anzueto; Russell P Bowler; Dawn L DeMeo; Alejandro A Diaz; Mark T Dransfield; Ashraf Fawzy; Marilyn G Foreman; Nicola A Hanania; Craig P Hersh; Victor Kim; Gregory L Kinney; Nirupama Putcha; Emily S Wan; J Michael Wells; Gloria E Westney; Kendra A Young; Edwin K Silverman; MeiLan K Han; Barry J Make
Journal:  Chest       Date:  2019-05-30       Impact factor: 9.410

Review 2.  Paradigms in chronic obstructive pulmonary disease: phenotypes, immunobiology, and therapy with a focus on vascular disease.

Authors:  Michael Schivo; Timothy E Albertson; Angela Haczku; Nicholas J Kenyon; Amir A Zeki; Brooks T Kuhn; Samuel Louie; Mark V Avdalovic
Journal:  J Investig Med       Date:  2017-03-03       Impact factor: 2.895

Review 3.  Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management.

Authors:  Nirupama Putcha; M Bradley Drummond; Robert A Wise; Nadia N Hansel
Journal:  Semin Respir Crit Care Med       Date:  2015-08-03       Impact factor: 3.119

4.  Childhood pneumonia increases risk for chronic obstructive pulmonary disease: the COPDGene study.

Authors:  Lystra P Hayden; Brian D Hobbs; Robyn T Cohen; Robert A Wise; William Checkley; James D Crapo; Craig P Hersh
Journal:  Respir Res       Date:  2015-09-21

Review 5.  Excess costs of comorbidities in chronic obstructive pulmonary disease: a systematic review.

Authors:  Manuel B Huber; Margarethe E Wacker; Claus F Vogelmeier; Reiner Leidl
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

6.  Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus.

Authors:  Craig P Hersh; Barry J Make; David A Lynch; R Graham Barr; Russell P Bowler; Peter M A Calverley; Peter J Castaldi; Michael H Cho; Harvey O Coxson; Dawn L DeMeo; Marilyn G Foreman; MeiLan K Han; Benjamin J Harshfield; John E Hokanson; Sharon Lutz; Joe W Ramsdell; Elizabeth A Regan; Stephen I Rennard; Joyce D Schroeder; Frank C Sciurba; Robert M Steiner; Ruth Tal-Singer; Edwin van Beek; Edwin K Silverman; James D Crapo
Journal:  BMC Pulm Med       Date:  2014-10-24       Impact factor: 3.317

Review 7.  Repurposing Treatments to Enhance Innate Immunity. Can Statins Improve Neutrophil Functions and Clinical Outcomes in COPD?

Authors:  Georgia M Walton; James A Stockley; Diane Griffiths; Charandeep S Sadhra; Thomas Purvis; Elizabeth Sapey
Journal:  J Clin Med       Date:  2016-10-11       Impact factor: 4.241

8.  Risk factors for cardiovascular disease in patients with COPD: mild-to-moderate COPD versus severe-to-very severe COPD.

Authors:  Laura Miranda de Oliveira Caram; Renata Ferrari; Cristiane Roberta Naves; Liana Sousa Coelho; Simone Alves do Vale; Suzana Erico Tanni; Irma Godoy
Journal:  J Bras Pneumol       Date:  2016 May-Jun       Impact factor: 2.624

9.  Management of the COPD Patient with Comorbidities: An Experts Recommendation Document.

Authors:  Jesús Recio Iglesias; Jesús Díez-Manglano; Francisco López García; José Antonio Díaz Peromingo; Pere Almagro; José Manuel Varela Aguilar
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-05-07

10.  Influence of comorbid heart disease on dyspnea and health status in patients with COPD - a cohort study.

Authors:  Maaike Giezeman; Mikael Hasselgren; Karin Lisspers; Björn Ställberg; Scott Montgomery; Christer Janson; Josefin Sundh
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.